BioCryst Announces Approval of ORLADEYO® (berotralstat) in United Arab Emirates

Company selects NewBridge Pharmaceuticals as regional distributor in Gulf Cooperation Council RESEARCH TRIANGLE PARK, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Ministry of…

BeiGene and NewBridge Pharmaceuticals Announce Approval in Saudi Arabia of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma

BeiGene and NewBridge Pharmaceuticals are working together to rapidly advance BRUKINSA in the Middle East and North African (MENA) region CAMBRIDGE, Mass. & BEIJING & DUBAI, United Arab Emirates–(BUSINESS WIRE)– BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused…

Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST® in the Middle East and North Africa

Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces it has entered into an exclusive licence agreement with NewBridge Pharmaceuticals (“NewBridge”) for the distribution of RUCONEST® (conestat…

NewBridge Pharmaceuticals -2018 winner of the Most Innovative Pharmaceutics Commercialisation Partner MENA award

“The www.CFI.co judging panel applauds the company’s mission to address unmet medical needs in the MENA region through strategic joint-ventures and partnerships, naming NewBridge Pharmaceuticals the 2018 winner of the…

NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019

Joe Henein, the President & CEO of NewBridge Pharmaceuticals, Sherif Hamdy Franchise Head Metabolic Care and Lina Sabbagh Commercial Lead CNS Lebanon attended the World Congress on Osteoporosis, Osteoarthritis and…

NewBridge Pharmaceuticals at EASL 2019

NewBridge President and CEO Joe Henein, Business Director Group Franchise Hisham EL Sayed and Brand Manager Rare Diseases Jennifer Bteich, attended The International Liver Congress “EASL 2019”, that was held…

Multiple Products, Multiple Geographies

TBY talks to Joe Henein, CEO of NewBridge Pharmaceuticals, on building brands, supporting SMEs in the region, and driving innovation. To read more, click on this link. Source Article: thebusinessyear…

First CPhI Middle East & Africa 2018 concludes in Abu Dhabi

On day 2 of CPhI Middle East & Africa 2018,  Joe Henein, CEO, NewBridge Pharmaceuticals delivered a session identifying the “Key challenges to bringing innovations to market”. Source Link:  Zawya…

NewBridge Pharmaceuticals attending the ASCO Annual Meeting 2018

NewBridge Pharmaceuticals team will  attend the American Society of  Clinical Oncology – ASCO Annual Meeting 2018 (1st to 5th of June, 2018) in Chicago headed by Chief Executive Officer, Joe…

12th International Pharmaceutical and Medical Device Compliance Congress

Joe Henein, President & CEO, NewBridge Pharmaceuticals is attending the 12th International Pharmaceutical and Medical Device Compliance Congress from 14th to 16th May, 2018 in Vienna, Austria.   Joe – as…